Cardiology - Original Articles

Unveiling atrial electromechanical delay in chronic obstructive pulmonary disease: an observational cohort study from north India

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 16 December 2024
Accepted: 30 March 2025
Published: 1 December 2025
241
Views
225
Downloads

Authors

Chronic obstructive pulmonary disease (COPD) is often associated with cardiovascular complications such as atrial fibrillation (AF), heart failure, and myocardial infarction. AF is highly prevalent in COPD, yet the mechanisms linking them remain unclear. This study investigates the role of atrial electromechanical delay (AEMD) in predicting cardiovascular outcomes in COPD patients. This prospective cohort study included 60 COPD patients (forced expiratory volume in 1 second/forced vital capacity <0.7) from August 2022 to March 2024. Patients with pre-existing heart disease and other major comorbidities were excluded. Participants underwent spirometry, electrocardiogram (ECG), echocardiography, and N-terminal pro b-type natriuretic peptide (NT-proBNP) testing. AEMD was measured at the lateral and medial mitral annuli and tricuspid annulus. Primary endpoints included AF incidence, heart failure, stroke, and COPD exacerbations, while secondary endpoints were hospitalization and mortality. AEMD values were significantly higher in patients with AF (75.4±5.9 ms vs. 70.4±4.1 ms, p=0.004), heart failure, and COPD exacerbations, particularly at the lateral and medial mitral annuli. AEMD at the tricuspid annulus was strongly associated with mortality (p=0.04). P wave dispersion (41.2±6.4 ms vs. 36.1±4.2 ms, p=0.001) and QT dispersion (49.3±8.9 ms vs. 42.1±6.8 ms, p=0.002) were significantly elevated in patients with adverse outcomes. Elevated NT-proBNP levels (>1000 pg/mL) correlated with prolonged AEMD, suggesting cardiac stress. AEMD, particularly at the mitral and tricuspid annuli, is a strong predictor of AF, heart failure, and COPD exacerbations. P wave and QT dispersion are associated with increased hospitalization and mortality, highlighting their role in risk stratification. These findings support the use of AEMD and ECG parameters as early markers for cardiovascular complications in COPD. Further validation in larger cohorts is needed.

Downloads

Download data is not yet available.

Citations

Quaderi SA, Hurst JR. The unmet global burden of COPD. Glob Health Epidemiol Genomics. 2018;3:e4. DOI: https://doi.org/10.1017/gheg.2018.1
Konecny T, Park JY, Somers KR, et al. Relation of chronic obstructive pulmonary disease to atrial and ventricular arrhythmias. Am J Cardiol. 2014;114:272-7. DOI: https://doi.org/10.1016/j.amjcard.2014.04.030
Yilmaz A, Can S, Perincek G, et al. Atrial electromechanical delay, neutrophil-to-lymphocyte ratio, and echocardiographic changes in patients with acute and stable chronic obstructive pulmonary disease. J Res Med Sci. 2022;27:64. DOI: https://doi.org/10.4103/jrms.JRMS_176_20
Cimci M, Borekci S, Kilickiran Avci B, et al. Assessment of atrial electromechanical delay and P wave dispersion in patients with chronic obstructive pulmonary disease. Turk Kardiyol Dern Ars. 2020;48:263-9. DOI: https://doi.org/10.5543/tkda.2019.58665
Rodríguez-Mañero M, López-Pardo E, Cordero A, et al. A prospective study of the clinical outcomes and prognosis associated with comorbid COPD in the atrial fibrillation population. Int J Chron Obstruct Pulmon Dis. 2019;14:371-80. DOI: https://doi.org/10.2147/COPD.S174443
Huang WC, Wu MF, Chen HC, et al. Features of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional study. NPJ Prim Care Respir Med. 2015;25:15063. DOI: https://doi.org/10.1038/npjpcrm.2015.63
Karaliute R, Jureviciute J, Jurgaityte J, et al. The predictive value of tissue Doppler indices for early recurrence of atrial fibrillation after electrical cardioversion. Clin Interv Aging. 2020;15:1917-25. DOI: https://doi.org/10.2147/CIA.S263303
Correale M, Totaro A, Ieva R, et al. Tissue Doppler imaging in coronary artery diseases and heart failure. Curr Cardiol Rev. 2012;8:43-53. DOI: https://doi.org/10.2174/157340312801215755
Grymonprez M, Vakaet V, Kavousi M, et al. Chronic obstructive pulmonary disease and the development of atrial fibrillation. Int J Cardiol. 2019;276:118-24. DOI: https://doi.org/10.1016/j.ijcard.2018.09.056
Nadeem R, Sharieff A, Tanna S, et al. Potential augmentation of the risk of ischemic cerebrovascular accident by chronic obstructive pulmonary disease in patients with atrial fibrillation. J Stroke Cerebrovasc Dis. 2015;24:1893-6. DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.04.034
Lopez CM, House-Fancher MA. Management of atrial fibrillation in patients with chronic obstructive pulmonary disease. J Cardiovasc Nurs. 2005;20:133-40. DOI: https://doi.org/10.1097/00005082-200503000-00009
Ortiz-Leon XA, Posada-Martinez EL, Trejo-Paredes MC, et al. Understanding tricuspid valve remodelling in atrial fibrillation using three-dimensional echocardiography. Eur Heart J Cardiovasc Imaging. 2020;21:747-55. DOI: https://doi.org/10.1093/ehjci/jeaa058
Goudis CA. Chronic obstructive pulmonary disease and atrial fibrillation: an unknown relationship. J Cardiol. 2017;69:699-705. DOI: https://doi.org/10.1016/j.jjcc.2016.12.013
Scheuermeyer FX, Mackay M, Christenson J, et al. There are sex differences in the demographics and risk profiles of emergency department patients with atrial fibrillation and flutter, but no apparent differences in ED management or outcomes. Acad Emerg Med. 2015;22:1067-75. DOI: https://doi.org/10.1111/acem.12750
Jagannatha GN, Antara IM, Kosasih AM, et al. P-wave peak time and P-wave dispersion in surface electrocardiography as initial predictors of new-onset atrial fibrillation in early-onset hypertension. Hypertens Res. 2024;47:137-48. DOI: https://doi.org/10.1038/s41440-023-01357-0
Kjaergaard J, Akkan D, Iversen KK, et al. Right ventricular dysfunction as an independent predictor of short- and long-term mortality in patients with heart failure. Eur J Heart Fail. 2007;9:610-6. DOI: https://doi.org/10.1016/j.ejheart.2007.03.001
Seyfeli E, Duru M, Kuvandık G, et al. Effect of obesity on P-wave dispersion and QT dispersion in women. Int J Obes. 2006;30:957-61. DOI: https://doi.org/10.1038/sj.ijo.0803233
Romiti GF, Corica B, Pipitone E, et al. Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients. Eur Heart J. 2021;42:3541-54. DOI: https://doi.org/10.1093/europace/euab116.143
Acikalin A, Satar S, Akpinar O, et al. NT-proBNP levels and QT changes in acute ischemic stroke. Neurol Asia. 2013;18:1-8.
Lin JF, Hsu SY, Wu S, et al. QT interval independently predicts mortality and heart failure in patients with ST-elevation myocardial infarction. Int J Med Sci. 2015;12:968-74. DOI: https://doi.org/10.7150/ijms.13121
Sievi NA, Clarenbach CF, Camen G, et al. High prevalence of altered cardiac repolarization in patients with COPD. BMC Pulm Med. 2014;14:1-8. DOI: https://doi.org/10.1186/1471-2466-14-55
Van Oekelen O, Vermeersch K, Everaerts S, et al. Significance of prolonged QTc in acute exacerbations of COPD requiring hospitalization. Int J Chron Obstruct Pulmon Dis. 2018;13:1937-47. DOI: https://doi.org/10.2147/COPD.S157630

Ethics Approval

The study protocol was approved by the Institutional Ethics Committee of Institute of Medical Sciences, Banaras Hindu University, Varanasi (Approval Number: [Dean/2022/EC/5056], Dated: 15.04.2023).

How to Cite



“Unveiling Atrial Electromechanical Delay in Chronic Obstructive Pulmonary Disease: An Observational Cohort Study from North India”. 2025. Monaldi Archives for Chest Disease, December. https://doi.org/10.4081/monaldi.2025.3306.